Source: Annual Congress 2012 - COPD treatment and varia
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Mustafina, O. Tsvetkova, E. Generozov (Moscow, Russian Federation). The pharmacogenetic effect of ADRB2 polymorphisms on therapeutic response in COPD. Eur Respir J 2012; 40: Suppl. 56, 3461

Member's Comments

No comment yet.

Related content which might interest you: Arg16Gly polymorphism of the β2-adrenergic receptor gene does not modulate clinical response to salmeterol in subjects with asthma Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment Year: 2008 Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1 Source: Eur Respir J 2006; 27: 682-688 Year: 2006 Associations between genetic polymorphisms and drug response phenotypes in patients with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007 CTLA4 polymorphisms and COPD Source: Eur Respir J 2010; 35: 457-458 Year: 2010 The influence of TNFα gene polymorphism on the therapeutic response in patients with sarcoidosis Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012 No association between COPD and ADAM33, TNF, EPHX1 and ADRB2 polymorphisms (SNPs) in a large case-control study Source: Eur Respir J 2006; 28: Suppl. 50, 584s Year: 2006 ß2-adrenergic receptor polymorphisms and risk of COPD Source: International Congress 2018 – Role of omics in population studies Year: 2018 Potential clinical utility of MUC5B and TOLLIP single nucleotide polymorphisms (SNP) in in the management of patients with IPF. Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 The role of 774C/T, -691C/T and 894G/T polymorphisms of NOS3 gene in development of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 316s Year: 2004 Investigating the role of IREB2 genetic variants in susceptibility to COPD Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012 Association of TGFB1 and IL4RnG2 gene polymorphisms with asthma Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012 Protective effect of intronic polymorphism rs324011 of STAT6 gene on asthma severity Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 The role of C/T polymorphism of NOS1 gene in COPD pathogenesis Source: Eur Respir J 2005; 26: Suppl. 49, 96s Year: 2005 Association of NRAMP1 gene polymorphisms with COPD clinical signs Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Association of NRAMP1 gene polymorphisms with COPD clinical signs Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 The role of LTA4H and ALOX5AP polymorphisms in asthma susceptibility Source: Eur Respir J 2007; 30: Suppl. 51, 130s Year: 2007 Genetic polymorphisms of the adrenergic ß2-receptor in COPD: systematic review and meta-analyses of disease risk and treatment response Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases Year: 2017 Association of IL4 gene polymorphisms with asthma phenotype Source: Annual Congress 2011 - Risk and detection of childhood asthma and allergy Year: 2011 Association of 781 C/T interleukin-8 gene polymorphism with asthma and COPD and possible impact on induced sputum inflammatory parameters Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases Year: 2010 Effects of Arg16Gly polymorphism in ADRB2 gene on responses to salmeterol or montelukast added to inhaled corticosteroids in Japanese asthmatic subjects Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012